Αποτελέσματα Αναζήτησης
25 Νοε 2019 · CapVest, which specializes in mid-market buyouts, has hired JPMorgan and Rothschild to find a new owner for the Paris-based firm which makes nuclear tracers used in diagnostic imaging ...
We continue to forge partnerships that are built on trust and accountability. Curium's focus is to develop, manufacture and supply world-class nuclear medicine products to customers around the globe. Find out who we are.
6 Απρ 2017 · “Today, I am excited to announce the uniting of IBA Molecular and Mallinckrodt Nuclear Medicine LLC to create Curium – a world-class provider in nuclear imaging,” says Renaud Dehareng, CEO of Curium.
Founders Renaud Dehareng. Operating Status Active. Legal Name Curium Holding France S.A.S. Company Type For Profit. Phone Number +33 1 69 85 76 76. Curium is a world-class nuclear medicine solutions provider with over 100 years of industry experience. Lists Featuring This Company. Ile-de-France Companies With More Than $100M in Revenue.
Curium's management team is focused on developing Curium into a global leader in nuclear medicine with an emphasis on service and new product development.
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
1 Ιαν 2021 · Information on valuation, funding, acquisitions, investors, and executives for Curium Pharma (Paris). Use the PitchBook Platform to explore the full profile.
